Illumina (NASDAQ:ILMN) Director David Walt unloaded 5,000 shares of the stock on the open market in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $78.34, for a total value of $391,700.00. Following the sale, the director now directly owns 936,488 shares of the company’s stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
A number of research firms have recently commented on ILMN. Analysts at Bank of America Corp. set a $90.00 price target on shares of Illumina in a research note to investors on Thursday. They now have a “buy” rating on the stock. Separately, analysts at Janney Montgomery Scott initiated coverage on shares of Illumina in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock. Finally, analysts at Wedbush raised their price target on shares of Illumina from $55.00 to $60.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock.
One analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $73.81.
Shares of Illumina (NASDAQ:ILMN) traded down 0.53% during mid-day trading on Friday, hitting $79.31. The stock had a trading volume of 523,353 shares. Illumina has a 52-week low of $40.71 and a 52-week high of $83.23. The stock has a 50-day moving average of $77.52 and a 200-day moving average of $68.54. The company has a market cap of $9.923 billion and a P/E ratio of 93.80.
Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $0.43 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter last year, the company posted $0.40 earnings per share. Illumina’s revenue was up 23.3% compared to the same quarter last year. On average, analysts predict that Illumina will post $1.73 earnings per share for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.